Literature DB >> 4863187

6-mercaptopurine (NSC-755) given intravenously at weekly intervals to patients with advanced cancer.

W Regelson, J F Holland, G L Gold, J Lynch, K B Olson, J Horton, T C Hall, M Krant, J Colsky, S P Miller, A Owens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4863187

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  2 in total

1.  A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors.

Authors:  P C Adamson; S Zimm; A H Ragab; S M Steinberg; F Balis; B A Kamen; T J Vietti; A Gillespie; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  6-mercaptopurine: high-dose 24-h infusions in goats.

Authors:  T J Schouten; R A De Abreu; E D Schretlen; J M van Baal; M B van Leeuwen; G A de Vaan
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.